Discuss the potential benefits of phentolamine mesylate (OraVerse) for post-anesthetic care for children
What will be an ideal response?
OraVerse (phentolamine mesylate), an injectable formulation by Novalar Pharmaceuticals, is the first pharmaceutical agent available for the reversal of soft-tissue anesthesia which often interfere with speaking, eating, and drinking. Additionally, there is early evidence that OraVerse may reduce the risks of postoperative soft tissue injury occurring during and after local anesthesia, especially in children.
Objective 7
True or false
You might also like to view...
A person is considered to have a normal blood pressure if their systolic reading is ________
A) less than 80. B) between 80 and 89. C) less than 120. D) between 120 and 139.
NFPA® codes classify manufacturing and processing facilities as ____ occupancies
A. business B. assembly C. industrial D. educational
Financial support for persons with mental illness who have not been able to establish a work history is available through ______________________.?
A) Supplemental Security Income (SSI) B) ?Social Security Disability Income (SSDI) C) the Substance Abuse and Mental Health Services Administration (SAMHSA) D) ?the Center for Mental Health Services (CMHS)
A disadvantage of using molybdenum for the anode material in mammography tubes is
a. less x-ray photon output. b. increased mAs required to maintain film density. c. increased patient dose. d. all of the above